{"database": "lobbying", "table": "lobbying_activities", "rows": [[1415053, "77ebc2d1-8547-48a6-a40b-8893694e722b", "Q2", "EMPIRE CONSULTING GROUP", 400703105, "PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA", 2013, "second_quarter", "PHA", "Issues relating to the Medicare Prescription Drug Act; issues relating to the Affordable Care Act; issues relating to the Independent Payment Advisory Board; H.R. 1588, \"Medicare Drug Savings Act of 2013\"; H.R. 1919, \"Safeguarding America's Pharmaceutical Act of 2013\"; and intellectual property issues.", "HOUSE OF REPRESENTATIVES", 30000, null, 0, 0, "2013-07-18T18:31:44.610000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1415053"], "units": {}, "query_ms": 0.7903310470283031, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}